Dividends & capital history

An overview of historical number of shares, dividends, stock buybacks and policy.

dividend-buyback-v2

Novozymes’ decision to buy back stock or issue extraordinary dividends is based on an assessment of the need for capital, capital structure optimization, and whether excess capital can be invested in profitable growth opportunities. Stock buybacks may also be carried out to cover employee stock option obligations.


Novozymes’ dividend pay-out ratio for 2015 was 37,6%. Novozymes continues to target an annual dividend payout ratio of around 40% of net profit.


The B common stock was reduced by DKK 13,400,000 from DKK 531,912,800 to DKK 518,512,800 shares following the approval at the Annual Shareholders' Meeting on February 24, 2015. A new stock buyback program worth up to DKK 2 billion and corresponding to around 7 million B shares was initiated on February 1, 2016

Full capital history including number of shares

Year
Dividend
per share
Share capital
(million)*
Average outstanding number
of shares (million)**
Average outstanding number
of shares (diluted, million)**
2015 3.50 626 306.0 309.4
2014 3.00 639 311.9 315.1
2013 2.50 639 313.8 317.4
2012 2.20 650 314.0 318.3
2011
1.90
650
315.2
320.0
2010
1.60
650
313.2
319.4
2009
1.15
650
310.3
315.3
2008
1.05
650
309.3
315.0
2007
1.00
650
309.6
318.1
2006
0.90
650
314.4
322.5
2005
0.80
696
327.3
335.3
2004
0.70
726
341.4
349.2
2003
0.63
754
352.3
354.3
2002
0.45
754
361.7
366.1
2001
0.40
754
368.1
371.4
2000
0.33
754
376.5
377.0